Prof Jobling is Director of Gynaecologic Oncology at Monash Medical Centre. He graduated from Monash University in 1980 and did his post graduate sub specialist training in Gynaecologic Oncology in London at the Royal Marsden and St Bartholomews hospitals. Professor Jobling has subsequently been elected as a Member of the Society of Pelvic Surgeons and is also Founder of the Ovarian Cancer Research Foundation (1999). He previously held the Chairmen position of Ovarian Cancer Research Foundation Board. His major interests are in radical surgery for ovarian cancer and the application of robotic surgery for gynaecological malignancy. Professor Jobling is an active member of a Research Team in bio marker detection and proteomics in ovarian cancer. He is involved as a collaborative investigator on several international clinical trials and is a Member of the Australia and New Zealand Gynaecologic Oncology Group, the Australian Society of Gynaecologic Oncology, the Victorian Co-operative Oncology Group and the International Society of Gynaecological Cancer.Prof jobling has Certificate of Gynaecological Oncology,
Doctor of Medicine, Head of Gynaecological Oncology at Monash Health.
Thomas Jobling
Follow
Get notifications in MyBN when activity occurs.
Thomas Jobling
Lists and Charts
Total Shareholder Return as at 01/12/25
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 294th | Blue Star Helium | 85.71% | -26.35% |
| 295th | West African Resources | 85.48% | 25.99% |
| 296th | Cleo Diagnostics | 85.29% | 0% |
| 297th | Carnegie Clean Energy | 85.19% | -2.24% |
| 298th | SSH Group | 84.77% | 0% |
1675 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
Lead Medical Advisor, Non-Executive Director
|
2022 - |
X